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Introduction
Fibroblast activation protein (FAP) belongs to the prolyl-cleaving peptidase family, which includes dipeptidyl peptidase 4 (DPP4), DPP8, DPP9, and DPP2. These enzymes preferentially cleave the peptide bond following a proline residue (1). Because this prolyl-cleaving activity is distinct from that of other cellular enzymes, this family of proteases is important in various cellular functions. In contrast to other proteases in the family, which are expressed ubiquitously (1), FAP is expressed exclusively in fetal cells, in wounded tissues, and in the stromal fibroblasts of more than 90% of malignant epithelial tumors, but it is not expressed in benign tumors or normal adult tissues (2) (3) (4) . The overexpression of FAP in xenographic animal models promotes cancer formation, supporting the direct involvement of FAP in cancer formation (5) . Because of its unique expression pattern and cancer-promoting capacity in animal models, FAP has long been proposed as an anticancer target.
Recently, an FAP inhibitor has been shown to be effective to inhibit tumor growth in syngeneic animal models (6) . Moreover, FAP is found to have immunosuppressive function in the tumor microenvironment (7) . Elimination of FAP-containing stromal cells allows the immune system to suppress the growth of solid malignant tumors (7) . How FAP exerts such function is not clear so far (7) .
FAP is a type II membrane serine protease and shares 50% of its sequence identity at the amino acid level with DPP4 (8, 9) . In contrast to the robust aminodipeptidase activity of DPP4, FAP is an endopeptidase with weak dipeptidase activity, equivalent to around 1% of the activity of DPP4 (8) .
Although FAP does not cleave type I or III collagen by itself (10, 11) , it cleaves the peptides into smaller fragments after matrix metallopeptidase 1 has digested these collagens (11) . FAP is capable of degrading recombinant gelatin (a denatured form of collagen) in vitro (9) . In the past few years, several studies have been performed to identify the cleavage-site specificity of FAP using a peptide library or the denatured protein gelatin. Consistent with its endopeptidase activity, FAP cleaves the Ac-P2-Pro-AFC substrate library with strict cleavage-site specificity, tolerating only Pro and Gly at the P1 and P2 sites, respectively (12) . A mass spectrometry study with gelatin as the substrate showed that FAP can cleave at this site when amino acids other than Pro occur at the P1 position, including Ala, Arg, Gly, Lys, and Ser (10) . The same study also reported that FAP prefers to cleave gelatin after either PPGP or the following sequence:
So far, only α 2 -antiplasmin (α 2 -AP) has been identified as being cleavable by FAP (13, 14) . α 2 -AP is a 51-kD protein involved in fibrin clot formation (14) . The binding of α 2 -AP to fibrin inhibits fibrinolysis (13) . FAP cleaves α 2 -AP after Pro 12 in the T 9 S 10 G 11 P 12 -N 13 Q 14 E 15 Q 16 E 17 sequence (Table   1 ). Based on the α 2 -AP cleavage sequence, a fluorescence resonance energy transfer (FRET) substrate library was generated (12) . Substrate profiling with this library indicated that FAP strictly requires Pro at P1, Gly at P2, and small uncharged residues such as Ser or Thr at P3 (12) . However, it lacks selectivity at P4, P1′, and P2′ in terms of the residues introduced in that study (12, 15) . Thus, the cleavage-site preferences reported in studies based on gelatin and α 2 -AP are not completely consistent (12, 13, 15) .
Because of the potential of FAP as an anticancer drug target, it is imperative to define its specificity to facilitate the identification of in vivo substrates and to understand its biological functions.
In this study, we used a full-length protein, SPRY2, to study the cleavage-site specificity of FAP. This analysis overcomes the limitations associated with the use of a peptide library or denatured gelatin, as reported previously. Our data demonstrate the cleavage-site specificities of FAP at the P3, P4, and P1′ sites.
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Materials and Methods
Plasmid construction
The plasmid pIRES2-EGFP-C-FLAG was constructed as described below. The FLAG tag was obtained by annealing, and PCR amplification was performed with the primers 5′-CCTAGTCGACATGGACTACAAGGACGATGACGACAAGTAGGGATCCATGC-3′ and 5′-GCATGGATCCCTACTTGTCGTCATCGTCCTTGTAGTCCATGTCGACTAGG-3′. The fragment was digested with SalI and BamHI, and then ligated into pIRES2-EGFP (Invitrogen) to produce pIRES2-EGFP-C-FLAG.
The full-length SPRY2 cDNA was amplified by PCR from a human Jurkat cell cDNA library with the primers 5′-CAGCTAGCATGGAGGCCAGAGCTCAG-3′ and 5′-CACTCGAGTGTTGGTTTTTCAAAGTT-3′, and cloned into the pCR ® -Blunt II-TOPO plasmid (Invitrogen). The SPRY2 DNA fragments were released by NheI and XhoI digestion, and ligated into pIRES2-EGFP-C-FLAG to produce pIRES2-SPRY2-C-FLAG for immunoprecipitation. Mutant SPRY2 was generated by site-directed mutagenesis, as described previously, with the primers summarized in Table 1S (16). The FAP expression plasmid for insect cells was constructed as described previously (8) . The plasmid for α 2 -AP expression in insect cells was constructed as follows.
The cDNA fragment encoding α 2 -AP, without the signal sequence, was amplified with the primers 5′-CTCGAGTATGGAGCCCTTGGGCTGG-3′ and 5′-CTCGAGTCACTTGGGGCTGCCAAAC-3′, and ligated into the pCR ® -Blunt II-TOPO vector. The DNA fragment was released from PCR-Blunt II-TOPO by XhoI digestion and ligated into pBac8-CD5 (16) to produce pBac8-CD5-His-α 2 -AP. CD5
is a cleavable signal sequence required for the extracellular secretion of the α 2 -AP protein (16) .
The plasmid for α 2 -AP expression in mammalian cells was constructed as follows. The fragment FLAG-α 2 -AP was amplified with the primers 5′-CGTCGACATGGACTACAAGGACGATGACGACAAGCTCGAGATGGAGCCCTTGGGC-3′
and 5′-CAGGATCCTCACTTGGGGCTGCCAAACTG-3′. The fragment was digested with SalI and BamHI, and ligated into pIRES2-EGFP-CD5 to produce pIRES2-CD5-FLAG-α 2 -AP. 
Purification of recombinant FAP and α 2 -AP proteins from insect cells
The growth and infection of Hi5 cells have been described previously (16, 17) . To obtain pure human FAP protein, a two-step purification process that coupled affinity chromatography with ion exchange chromatography was used. The purification process of affinity chromatography was performed as described previously (16, 17) . More specifically, the culture medium of Hi5 cells expressing FAP was collected and precipitated by adding 3.8 M ammonium sulfate, up to 70% saturation. The pellet was re-suspended in the binding buffer, which contains 20 mM Tris -HCl buffer, pH 8.0, with 500 mM NaCl and then passed through the Ni-sepharose column. Three to five times the bed volume of the binding buffer containing 10 mM or 20 mM imidazole was used to wash the column. To isolate the FLAG-tagged α 2 -AP protein from the medium, the culture medium of the transfected 293A cells was collected and concentrated with an Amicon YM-10 ultrafiltration device.
To isolate the SPRY2-Flag protein from the cell lysate, the 293A cells were collected after transfection for 48 h and lysed in lysis buffer (50 mM Tris-HCl [pH 7.4], 150 mM NaCl, 1 mM EDTA, and 1%
Triton X-100) supplemented with EDTA-free Protease Inhibitor Cocktail (Roche). The FLAG-tagged To set up the in vitro cleavage reaction, we first purified FAP from insect cells using a two-step chromatographic procedure to ensure its high purity, to minimize nonspecific cleavage (Fig. 1A) .
Subsequent gel filtration neither improved the purity greatly nor changed the results reported in this study (data not shown). The measured kinetic constant indicated that the purified enzyme was active
Using a method similar to that used to purify FAP, we also obtained α 2 -AP from insect cells (Fig. 1B) . The molecular mass of α 2 -AP (around 65 kD) was slightly smaller than that reported in mammalian cells (around 70 kD) (Fig. 1C) , indicating that the α 2 -AP from insect cells might be less glycosylated. This is not unusual because many proteins are less glycosylated in insect cells than in mammalian cells (18) .
Next, α 2 -AP was incubated with FAP for various times at 37°C, and the cleavage of α 2 -AP by FAP was detected either in a Coomassie-Blue-stained SDS-PAGE gel or by western blot analysis using an anti-His antibody. 2F09 is a potent and selective chemical inhibitor of FAP, with an IC 50 for FAP of 22 nM (named compound 19 in the paper) (19) . It effectively inhibits the enzymatic activity of FAP at 10 μM and this compound was included as the control (Fig. 1B and 1C ). As shown in Fig. 1B , the cleavage of α 2 -AP by FAP was readily detectable in western blot analysis. Not knowing whether the glycosylation of α 2 -AP affects its cleavage, we then expressed FLAG-tagged α 2 -AP in mammalian 293A cells and captured the protein by immunoprecipitation (Fig. 1C) . As shown in Fig. 1C (Fig. 1D ). SPRY2 (also called SPROUTY2) is a known receptor tyrosine kinase inhibitor located inside cells (20) . Therefore, it is not an in vivo substrate of FAP. Nevertheless, we wished to delineate the cleavage-site specificity of FAP in the context of a full-length globular protein.
A time course study of cleavage by FAP was carried out (Fig. 1D) . Quantification of the rate of cleavage clearly was done with Image J software (http://rsbweb.nih.gov/ij/). The data clearly showed that SPRY2 was a much more robust substrate of FAP than α 2 -AP (Fig. 1E) , and was more suitable as a protein substrate to study the cleavage preferences of FAP. There is only one potential FAP cleavage site in SPRY2 with the sequence SSGPVA, with P at position 144 ( Fig. 2A and Table 1 ). Consistent with the importance of Pro144, mutation of P144 to Leu effectively abolished the cleavage of SPRY2
by FAP (Fig. 2B ).
Cleavage-site specificity of FAP for SPRY2
Site-directed mutagenesis was carried out to mutate P3, P4, P1′ and P2′ sites of SPRY2 targeting SSGP-VA. The mutant proteins were immunoprecipitated after their expression in mammalian cells and then incubated with purified FAP for 8 h or 16 h. Quantification of the cleavage with SPRY2 remained was done with Image J software and shown below each panel. For P3, P4 and P1′ sites, we changed each site individually to acidic (D), basic (R and H), hydrophobic (P and L), or small hydrophilic (G, S, and A) residues. FAP showed strict selectivity at the P1′ site ( Fig. 3A and 3B ).
With P at P1′ site, SPRY2 was not cleaved even after incubation for 16 h. SPRY2 with either R or D at P1′ site was not cleaved significantly after incubation for 8 h, but more R mutant proteins were cleaved than D after incubation for 16 h. In comparison, both small uncharged and bulky hydrophobic residues were tolerated at P1′ site. With P or R at P2′ site, SPRY2 was cleaved after incubation for 16 h, indicating greater selectivity for P1′ site than for P2′ site (Fig. 2C) .
SPRY2 with R, D, or P at P3 site was not cleaved significantly by FAP after incubation for 16 h (Fig. 3C and 3D ), suggesting that charged residues are less tolerated at P3. In contrast, SPRY2 proteins with small uncharged amino acids and large hydrophobic amino acids at P3 site were cleaved after incubation for 16 h (Fig. 3C and 3D ). Compared with P3 site, no significant selectivity was found at the P4 site, and all mutant SPRY2 proteins were cleaved to various extent after incubation for both 8 h and 16 h (Fig. 3E and 3F ). Among them, D at P4 site is the least favored substrate.
Molecular docking of the SPRY2 cleavage site to the FAP active site
The SSGPVA peptide, corresponding to the cleavage site of SPRY2 (amino acids 141-146), was manually docked to the active site of FAP (Fig. 4) . Like that of DPP4, the S1 subsite of FAP contains a number of hydrophobic residues, including Y625 (equivalent to DPP4 Y631), V650 (V656), W653
(W659), Y656 (Y662), Y660 (Y666), and V705 (V711), which are ideal for anchoring a substrate with proline at the P1 position. Furthermore, the hydroxyl oxygens of these tyrosines, along with two glutamates (E203 and E204) and one aspartate (D703), contribute to form an acidic environment for substrate binding (Fig. 4) . This is consistent with the substrate profiling of the SPRY2 protein, in that we found that substitution of D to P1′, P3 and P4 sites render the proteins least cleavable by FAP (Fig.   3B , 3D and 3F).
By overlaying on the SPRY2 peptide and conducting energy minimization that followed, docking models of the α2-AP peptide and the two interleukin peptides were also produced (data not shown).
However, probably owing to the primitive energy minimization and overlaying technique used, no notable differences were observed among the different docking models. Nevertheless, an acidic binding site is consistent with the observed low cleavage activities of the interleukins, which have negatively charged residue (glutamate) at either P4 or P2′ site.
Discussion
FAP has long been considered a promising anticancer target molecule. In human clinical samples, a greater amount of FAP in stromal fibroblast cells is associated with worse patient survival and more aggressive disease progression and metastasis (21) . Cancer treatment using either FAP inhibitors or immunotherapy directed against the FAP antigen has been effective in different animal models (5, 6, (22) (23) (24) . However, a human clinical trial with a weak and nonselective FAP inhibitor was terminated because of renal toxicity (24, 25) . Treatment with anti-FAP antibody was also ineffective in human patients (26) . At present, the biological functions of FAP must be better understood to confirm its potential as an anticancer target. Investigation of its cleavage-site specificity should help us identify the in vivo substrate of FAP and its function.
To gain more insight into the substrate specificity of FAP, we investigated its cleavage-site preference using a native, full-length protein. All studies reported so far have used either a short peptide library or the denatured protein gelatin. Our first attempt to use full-length α 2 -AP protein to delineate the specificity of FAP yielded little information. The cleavage of FLAG-tagged α 2 -AP expressed in mammalian cells was very slow (Fig. 1C) . Although SPRY2 is not a real substrate of FAP, it is a much more robust substrate of FAP than is α 2 -AP. Unlike the results obtained in a peptide library study (15) , FAP cleaved both small uncharged amino acids and bulky hydrophobic amino acids at P1′, P3 and P4
sites. Charged amino acids were not preferred by FAP at these position, especially the acidic residue. This is a new finding and has not been observed before in studies based on a peptide substrate library or gelatin. Consistent with this, interleukins cannot be cleaved by FAP possibly due to the fact that they have glutamate on one side or the other of the proline. As shown in Figure 4 , the substrate binding site of FAP has an acidic electrostatic surface, contributed in part by two glutamate (E203 and E204) and one aspartate (D703) residues. This could explain why glutamate at either end of the interleukin peptide would not be tolerated. In addition to the information provided from the study of Lee et al. (2009) , the present work suggests that negatively charged residues should be avoided in designing peptide inhibitors of FAP. Moreover, some aromatic moieties may interact favorably with the multiple tyrosine residues at certain sites. Similarly, a hydrophobic residue such as alanine could be favored compared to glutamine at P2′ site, making SPRY2 a more robust substrate than α2-AP. Consistent with our findings, mutational analysis (Lee et al., 2009) showed that alaine is better than glutamine at P2′ and seriene is better than threonine at P4, both favoring SPRY2 over α2-AP.
Interestingly, we found that FAP could not cleave SPRY2 when a proline occurred at the P1′ site (Fig. 3A) . However, proline was tolerated at the P3, P4, or P2′ site (Figs 2 and 3 cleave the peptide bond between two prolines at P1-P1′ (27) . It is also well known that other serine proteases, including trypsin, chymotrypsin, and elastase, cannot cleave at the P1 site if the P1′ site is occupied by proline (28, 29) . This may be because the lack of hydrogen on the imino group of the imidazole ring of proline at P1′ affects the formation of an oxyanion hole, which prevents cleavage by these serine proteases.
The active site of FAP is accessible through two openings (8) . One is the tunnel formed by the eight blades of the β-propeller domain, and the other, called the "side opening", is a cavity between the propeller and the hydrolase domains (8) . From the docking results, it seems that the side opening is the more likely route for peptide entry, judging from the orientation of the peptide in the active site pocket, although this requires confirmation with further biochemical and structural studies. Our data also demonstrate that proline is essential at the P1 site (Fig. 2B) . It is not clear to us whether the cleavage after Ala, Arg, Gly, Lys, or Ser at the P1 site, which was observed and reported using gelatin as the substrate, can be attributed to the impurity of the FAP enzyme used in that assay (10) . In the past, we observed nonspecific cleavage by DPP4 when only one-step affinity purification was used (Han, Y.S.
and Chen, X. unpublished observation). We believe that the purity of FAP in this kind of in vitro study is critical. FAP must be as pure as possible to evaluate its cleavage-site specificity. Because information is unavailable on the real in vivo substrates of FAP, other than α 2 -AP, the discovery of the 
